Treatment for Presumed Ocular Histoplasmosis

Phase 1/2 Unknown 40 enrolled John Kitchens, MD

RandomizedParallel-groupOpen-labelTreatment

Summary

The purpose of this study is to monitor safety outcomes for patients being treated with intravitreal aflibercept injections for choroidal neovascularization secondary to Presumed Ocular Histoplasmosis Syndrome.

Timeline

Start: 2013-03
Primary completion: 2014-08
Completion: 2014-08

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Aflibercept	Protein / enzyme biologic	—	Intravitreal

Treatment for Presumed Ocular Histoplasmosis

Summary

Timeline

Drugs

Indications